PureTech Health said it will begin human trials on an experimental treatment for respiratory complications following recovery from COVID-19 infections. Read More

Novartis-subsidiary AveXis has entered into an agreement to manufacture a COVID-19 vaccine being developed by Massachusetts General Hospital and Massachusetts Eye and Ear. Read More

Top pharmaceutical executives pushed back yesterday against the World Health Organization’s plan for sharing patent rights and product data for COVID-19 countermeasures. Read More

GlaxoSmithKline (GSK) said it plans to manufacture 1 billion doses of its vaccine adjuvant next year to support multiple COVID-19 vaccine candidates. Read More

Roche has begun a phase 3 trial of its rheumatoid arthritis treatment Actemra (tocilizumab) with Gilead Sciences’ remdesivir for treatment of patients with severe COVID-19 pneumonia. Read More

The agreement will begin immediately to address Moderna's increasing demand over the upcoming months and will focus on securing future long-term supply. Read More

Maryland-based Novavax is expanding its manufacturing capacity for its COVID-19 vaccine candidate by acquiring a manufacturer in the Czech Republic as drugmakers rush to prepare for the global deployment of a successful vaccine. Read More

The FDA spelled out in a new guidance released yesterday how it will conduct formal meetings and deal with new drug applications during the COVID-19 pandemic. Read More

A Seattle-based study of how COVID-19 spreads through the community has put its project on hold at the FDA’s request until it receives an Emergency Use Authorization (EUA) for its lab-developed test and self-swab kit. Read More

Anthony Fauci, director of the NIH’s National Institute for Allergy and Infectious Diseases (NIAID), said yesterday that he still believes a COVID-19 vaccine could be deployed by the end of the year. Read More